Identification of Medication Adherence Barriers intervention
The Identification of Medication Adherence Barriers Questionnaire intervention (IMAB-Qi) research programme is a one year programme to develop a trial to evaluate the effectiveness and cost-effectiveness of a primary care medication adherence intervention.
Development of the IMAB-Q
The intervention in the IMAB-Qi study will involve using the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) to support practitioners and patients to work together to address medication non-adherence.
The IMAB-Q was developed through a review of the literature, mapping individual barriers to the Theoretical Domains Framework and focus groups with people prescribed medication to get a better understanding of the barriers to medication adherence.
Discover how the IMAB-Q was developed and validated.
The IMAB-Qi research programme
The IMAB-Qi programme comprises three phases:
1. Convening a Primary Care Influencer Group
2. Developing a Core Outcome Set for medication adherence trials
Information for patients and carers:
- Invitation letter for patients and carers (PDF, 112kb)
- Information sheet for patients and carers (PDF, 229kb)
Information for practice teams and academics:
3. Defining how to operationalise the IMAB-Qi
The study is funded by the National Institute for Health and Care Research. Find out more about the research programme.
Meet the study team
Dr Jackie Martin-Kerry